Drug intelligence / Profile preview

Anduolin

Development stage: Preclinical
Administration: Oral

Overview

Anduolin is a Chinese material medical decoction compound that was investigated in a preclinical study for its potential protective effects against acute radiation injury in the testis of mice. It was administered orally for two weeks prior to whole-body irradiation. The specific composition and mechanism of action of Anduolin are not detailed in the provided context, nor are its specific therapeutic outcomes.

Beyond the preview

Go deeper on Anduolin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anduolin.

Explore the full profile